Comparing Antimicrobial Susceptibilities among Mycoplasma pneumoniae Isolates from Pediatric Patients in Japan between Two Recent Epidemic Periods | Zendy

Tomohiro Oishi | Zendy; Kento Takahashi | Zendy; Shoko Wakabayashi | Zendy; Yoshitaka Nakamura | Zendy; Sahoko Ono | Zendy; Mina Kono | Zendy; Atsushi Kato | Zendy; Aki Saito | Zendy; Eisuke Kondo | Zendy; Yuhei Tanaka | Zendy; Hideto Teranishi | Zendy; Hiroto Akaike | Zendy; Takaaki Tanaka | Zendy; Ippei Miyata | Zendy; Satoko Ogita | Zendy; Naoki Ohno | Zendy; Takashi Nakano | Zendy; Kazunobu Ouchi | Zendy

Open Access

Comparing Antimicrobial Susceptibilities among Mycoplasma pneumoniae Isolates from Pediatric Patients in Japan between Two Recent Epidemic Periods

Author(s) -

Tomohiro Oishi,

Kento Takahashi,

Shoko Wakabayashi,

Yoshitaka Nakamura,

Sahoko Ono,

Mina Kono,

Atsushi Kato,

Aki Saito,

Eisuke Kondo,

Yuhei Tanaka,

Hideto Teranishi,

Hiroto Akaike,

Takaaki Tanaka,

Ippei Miyata,

Satoko Ogita,

Naoki Ohno,

Takashi Nakano,

Kazunobu Ouchi

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.02517-18

Subject(s) - mycoplasma pneumoniae , antimicrobial , microbiology and biotechnology , virology , medicine , mycoplasma , biology , pneumonia

We compared the antimicrobial susceptibility of Mycoplasma pneumoniae isolates from pediatric patients in Japan in 2011-2012 and 2015-2016, when epidemics occurred. The antimicrobial activity of macrolides and tetracyclines against M. pneumoniae infection tended to be restored in 2015-2016. There was no change in the antimicrobial activity of quinolones against M. pneumoniae infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research